Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-06-12FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
FDA approved a supplemental application for BERKLEY AND JENSEN OMEPRAZOLE (omeprazole) submitted by BJWC.
-
FDA approval · 2018-06-07FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID (lansoprazole) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Omeprazole by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole from Sandoz Inc, enabling the continued marketing of the generic omeprazole produ…
-
FDA approval · 2018-06-07FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
The FDA approved a supplemental application for Esomeprazole Strontium submitted by R2 Pharma, LLC under NDA202342.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application (ANDA 203270) for Omeprazole from Aurobindo Pharma Limited, authorizing changes to an approved gener…
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Golden State Medical Supply, Inc.)
The FDA approved a supplemental application for the generic omeprazole from Golden State Medical Supply, Inc., authorizing changes to the ap…
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for the generic Omeprazole from Lannett Company, Inc., granting continued approval for this prod…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects [Phase 1, Phase 2]
A completed Phase 1/2 trial comparing the GI safety of a 14-day oral regimen of ATB-346 to sodium naproxen in healthy subjects.
-
FDA approval · 2018-05-31FDA Approved: OMEPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for omeprazole from Aurobindo Pharma Limited, authorizing their generic omeprazole product.
-
FDA approval · 2018-05-31FDA Approved: OMEPRAZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's supplemental application for omeprazole, granting approval for the generic proton pump inhibitor product. This a…
-
FDA approval · 2018-05-31FDA Approved: OMEPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for omeprazole from Dr. Reddy's Laboratories Limited under the ANDA pathway.
-
FDA approval · 2018-04-30FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Sun Pharmaceutical Industries, Inc)
The FDA approved Sun Pharmaceutical's original application for Esomeprazole Magnesium, a proton pump inhibitor. It is used to treat gastroes…
-
FDA approval · 2018-04-24FDA Approved: RABEPRAZOLE SODIUM — Original Application (Ascend Laboratories, LLC)
FDA approved Rabeprazole sodium from Ascend Laboratories, LLC as an Original Application (ANDA 208644), authorizing a generic proton pump in…
-
FDA approval · 2018-04-13FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID Solutab (lansoprazole) from Takeda Pharmaceuticals America, Inc., indicating a regu…
-
FDA label_change · 2018-02-28FDA Approved: CYTOTEC — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Cytotec (misoprostol) from Pfizer, resulting in an update to the product labeling.
-
FDA approval · 2018-01-25FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for a combination product containing bismuth subcitrate potassium, metronidazole, and tetracycline h…
-
FDA approval · 2018-01-24FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) submitted by Haleon US Holdings LLC. The action …
-
FDA approval · 2018-01-09FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) filed by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents [NA]
Terminated clinical trial evaluating if second-look endoscopy reduces peptic ulcer rebleeding in patients who resume antiplatelet therapy ea…
-
FDA approval · 2017-11-15FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) filed by Wal-Mart Stores Inc. The action relates to this …
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Healing Effects of Autologous Platelet Rich Plasma on Gastric Ulcer Caused by Endoscopic Submucosal Dissection [Phase 3]
Phase 3 trial completed evaluating the healing effects of autologous platelet-rich plasma on gastric ulcers caused by endoscopic submucosal …
-
FDA approval · 2017-10-30FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole), with AmerisourceBergen as the manufacturer, …
-
FDA approval · 2017-10-18FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Prevacid Solutab (lansoprazole) by Takeda Pharmaceuticals America, Inc., related to the Solu…
-
FDA approval · 2017-09-28FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole by Sandoz Inc (ANDA 076515).